The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer’s Disease

Author： Ojala Johanna O.   Sutinen Elina M.  

Publisher： MDPI

E-ISSN： 2077-0383|6|5|55-55

ISSN： 2077-0383

Source： Journal of Clinical Medicine, Vol.6, Iss.5, 2017-05, pp. : 55-55

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders

By Stepien Karolina M.   Heaton Robert   Rankin Scott   Murphy Alex   Bentley James   Sexton Darren   Hargreaves Iain P.  

Journal of Clinical Medicine, Vol. 6, Iss. 7, 2017-07 ,pp. : 71-71

MDPI

Access to resources Recommend Favorite

Newly Synthesized Acetylcholinesterase Inhibitors for Alleviating Alzheimer’s Disease using Solid Lipid Nanoparticles

By  

Current Drug Therapy, Vol. 9, Iss. 2, 2014-06 ,pp. : 111-123

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologie de la maladie d’Alzheimer : vision du futur: Pharmacology of Alzheimer’s Disease: Where Do We Go from Here?

By Sellal François  

Therapie, Vol. 60, Iss. 2, 2005-01 ,pp. : 89-107

Adis International

Access to resources Recommend Favorite

Disease overview - Alzheimer's disease

By Clark Richard  

Drugs In Context, Vol. 1, Iss. 1, 2005-02 ,pp. : 5-16

CSF Medical Communications Ltd

Access to resources Recommend Favorite

The Role of Th17 Cells in the Pathogenesis of Behcet’s Disease

By Nanke Yuki   Yago Toru   Kotake Shigeru  

Journal of Clinical Medicine, Vol. 6, Iss. 7, 2017-07 ,pp. : 74-74

MDPI

Access to resources Recommend Favorite